TacticScaleWhat Conmed Does & How It Makes Money (CNMD)
Updated October 2026 · reflects Conmed's latest reported financials
Medical device maker of surgical tools for orthopedic and general surgery. CONMED sells surgical capital equipment such as generators, power tools, and insufflation and visualization systems, along with the related single-use products and implants those systems use.
How Conmed makes money
CONMED sells surgical capital equipment such as generators, power tools, and insufflation and visualization systems, along with the related single-use products and implants those systems use. It sells directly to hospitals, surgery centers, and other healthcare institutions, and also through medical specialty distributors.
What Conmed does
CONMED Corporation is a medical technology company, founded in 1970 and based in Largo, Florida, that develops, manufactures, and sells devices for surgical procedures. Its orthopedic business covers sports medicine: soft tissue fixation and augmentation products such as BioBrace, TruShot with Y-Knot, and Y-Knot and Argo knotless suture anchors, plus powered resection, fluid management, and visualization systems for arthroscopic surgery. It also sells Hall-branded battery-powered bone power tools used across orthopedic, spinal, oral/maxillofacial, podiatric, and cardiothoracic surgery. In general surgery, CONMED offers AirSeal insufflation systems, Buffalo Filter smoke removal devices, endomechanical instruments including Anchor1 tissue retrieval bags and trocars, and electrosurgical generators with their accessories. The company also supplies endoscopic products for gastroenterology and patient monitoring disposables such as ECG and EEG electrodes and defibrillation pads. It reaches customers through direct sales to hospitals and surgery centers and through specialty distributors, pairing its equipment with recurring single-use products.
Products & services
- AirSeal insufflation systems
- Buffalo Filter smoke removal
- Hall surgical power tools
- Y-Knot all-suture anchors
- BioBrace
- Anchor1 tissue retrieval bags
What is Conmed worth?
On an owner-earnings DCF, Conmed's most-likely value is about $84 versus a recent price near $44 (90% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~$47) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
⚠ High leverage — net debt is 5.9× annual cash flow. Net debt is subtracted from this fair value, but refinancing at higher rates, principal timing, and share dilution aren’t modeled — the equity can be worth far less if cash flow weakens.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Medtronic (MDT) · Merit Medical Systems (MMSI) · Boston Scientific (BSX) · Solventum (SOLV) · TransMedics (TMDX)